Zobrazeno 1 - 10
of 141
pro vyhledávání: '"59"'
Autor:
Merry L. Lindsey, Kevin A. Kupzyk, Scott Lundgren, Joseph F. Norman, Bunny Pozehl, Alfred L. Fisher, Steven J. Keteyian, Windy Alonso
Publikováno v:
J Card Fail
Background Despite exercise being one of few strategies to improve outcomes for individuals with heart failure with preserved ejection fraction (HFpEF), exercise clinical trials in HFpEF are plagued by poor interventional adherence. Over the last 2 d
Autor:
Philip S. Helliwell, J. Erickson, Eric Lespessailles, Hideto Kameda, Roy Fleischmann, Ruben Burgos-Vargas, S. Rathmann, Vinod Chandran, Catherine L Shuler, Gaia Gallo, Désirée van der Heijde, Aubrey Trevelin Sprabery, Julie Birt
Publikováno v:
Rheumatology, 59(10), 2774-2784. OXFORD UNIV PRESS
Rheumatology
Rheumatology, Oxford University Press (OUP), 2020, 59 (10), pp.2774-2784. ⟨10.1093/rheumatology/kez684⟩
Rheumatology (Oxford, England)
Rheumatology
Rheumatology, Oxford University Press (OUP), 2020, 59 (10), pp.2774-2784. ⟨10.1093/rheumatology/kez684⟩
Rheumatology (Oxford, England)
Objective The aim was to assess the safety and efficacy of up to 156 weeks of ixekizumab (an IL-17A antagonist) treatment in PsA patients. Methods In a phase III study, patients naïve to biologic treatment were randomized to placebo, adalimumab 40 m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22351d4deab772a061099af31fb50c3b
https://academic.oup.com/rheumatology/article/59/10/2774/5730209
https://academic.oup.com/rheumatology/article/59/10/2774/5730209
Publikováno v:
Repositório Institucional da UFMG
Universidade Federal de Minas Gerais (UFMG)
instacron:UFMG
Cochrane Database Syst Rev
Universidade Federal de Minas Gerais (UFMG)
instacron:UFMG
Cochrane Database Syst Rev
Chronic venous insufficiency (CVI) is a progressive and common disease that affects the superficial and deep venous systems of the lower limbs. CVI is characterised by valvular incompetence, reflux, venous obstruction or a combination of these sympto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::129216c5756e37f295f2e064df08c070
https://orcid.org/0000-0002-9940-2119
https://orcid.org/0000-0002-9940-2119
Autor:
James D. Chalmers, Oriol Sibila, Amelia Shoemark, Elena Laserna, Wim Boersma, Lidia Perea, Megan Crichton, Diana Bilton, Josje Altenburg, Anthony De Soyza
Publikováno v:
Sibila, O, Laserna, E, Shoemark, A, Perea, L, Bilton, D, Crichton, M L, de Soyza, A, Boersma, W G, Altenburg, J & Chalmers, J D 2022, ' Heterogeneity of treatment response in bronchiectasis clinical trials ', The European respiratory journal, vol. 59, no. 5 . https://doi.org/10.1183/13993003.00777-2021
European respiratory journal, 59(5). European Respiratory Society
The European respiratory journal, 59(5). European Respiratory Society
European respiratory journal, 59(5). European Respiratory Society
The European respiratory journal, 59(5). European Respiratory Society
BackgroundRecent randomised clinical trials in bronchiectasis have failed to reach their primary end-points, suggesting a need to reassess how we measure treatment response. Exacerbations, quality of life (QoL) and lung function are the most common e
Autor:
Janelle Yorke, Cordula Cadus, John Linnell, Peter Horvath, Zsofia Lazar, Rosa Faner, Michael R. Jacobs, Fekri Abroug, Alexander G. Mathioudakis, Vanessa M. McDonald, Marco Contoli, Sachin Ananth, Galina Sergeeva, Pradeesh Sivapalan, Guy Brusselle, Alberto Papi, Hao Wang, Konstantinos Kostikas, Bianca Beghe, Agni Sioutkou, Gerard J. Criner, Jens-Ulrik Stæhr Jensen, Thomas Bradbury, Alejandra López-Giraldo, Andras Bikov, Joerg D. Leuppi, Courtney Coleman, Elizabeth Stovold, Carol Liddle, Alexander Emelyanov, Rune Nielsen, Guy Joos, Jørgen Vestbo, Christine Jenkins, Paula R Williamson, Gustavo Fernandez Romero, Alvar Agusti, Olga Kharevich, Isabel Saraiva, Fuqiang Wen, Balázs Csoma, Elena Lapteva, Arturo Humberto Huerta Garcia, Zeineb Hammouda, Olga Corlateanu, Decode-Net, Konstantinos Bartziokas, Alexandru Corlateanu, Per Bakke
Publikováno v:
Mathioudakis, A G, Abroug, F, Agusti, A, Ananth, S, Bakke, P, Bartziokas, K, Beghe, B, Bikov, A, Bradbury, T, Brusselle, G, Cadus, C, Coleman, C, Contoli, M, Corlateanu, A, Corlateanu, O, Criner, G J, Csoma, B, Emelyanov, A, Faner, R, Romero, G F, Hammouda, Z, Horváth, P, Garcia, A H, Jacobs, M, Jenkins, C, Joos, G, Kharevich, O, Kostikas, K, Lapteva, E, Lazar, Z, Leuppi, J D, Liddle, C, Linnell, J, López-Giraldo, A, McDonald, V M, Nielsen, R, Papi, A, Saraiva, I, Sergeeva, G, Sioutkou, A, Sivapalan, P, Stovold, E, Wang, H, Wen, F, Yorke, J, Williamson, P R, Vestbo, J, Jensen, J U & DECODE-NET 2022, ' ERS statement : A core outcome set for clinical trials evaluating the management of COPD exacerbations ', European Respiratory Journal, vol. 59, no. 5, 2102006 . https://doi.org/10.1183/13993003.02006-2021
European Respiratory Journal, 59(5):2102006
European Respiratory Journal, 59(5):2102006
Clinical trials evaluating the management of acute exacerbations of COPD assess heterogeneous outcomes, often omitting those that are clinically relevant or more important to patients. We have developed a core outcome set, a consensus-based minimum s
Autor:
Dakshika Jeyaratnam, Achyut Guleri, Denise Ward, Gonzalez-Ruiz Armando, Martin Wiselka, Julia Greig, Clive Graham, R. Cunningham, Bernadette C. Young, David Harvey, Jonathan D. Edgeworth, Paul R. Chadwick, Matthew Scarborough, Janet Cairns, Guy E. Thwaites, Robert Tilley, Julian Sutton, M. Estée Török, Paul McWhinney, John Williams, Peter R. Wilson, A. Sarah Walker, Deepa Nayar, Pankaj Lal, Gavin Barlow, Emmanuel Nsutebu, Marta Soares, Neil Jenkins, Alexander J. Szubert, Pedro Saramago Goncalves, Sarah A Wyllie, Jennifer Bostock, Cressida Auckland, David Price, Jane Minton, N. Claire Gordon, Susan Hopkins, Sarah Meisner, T. Planche, Fleur Hudson, Martin J. Llewelyn
Publikováno v:
Health Technology Assessment, Vol 22, Iss 59 (2018)
BackgroundStaphylococcus aureusbacteraemia is a common and frequently fatal infection. Adjunctive rifampicin may enhance earlyS. aureuskilling, sterilise infected foci and blood faster, and thereby reduce the risk of dissemination, metastatic infecti
Publikováno v:
Journal of Cancer Education. 29:175-180
In the setting of breast oncology consultations, we sought to understand communication patterns between patients with advanced breast cancer and their oncologists during visits with Decision Support Services. This is a descriptive study analyzing the
Autor:
Danielle Wurzel, Suzanna Vidmar, Phillip Pattie, Arest Cf, Rachel E. Foong, Graham L. Hall, Sarath Ranganathan, Kathryn A. Ramsey, Joanne Harrison, Alana Harper
Publikováno v:
Journal of Cystic Fibrosis. 21:e188-e203
Background There is no data exclusively on the relationship between health-related quality-of-life (HRQOL) and lung disease severity in early school-aged children with cystic fibrosis (CF). Using data from the Australian Respiratory Early Surveillanc
Publikováno v:
Complementary Therapies in Medicine. 17:23-28
Summary Objectives The aim of this trial was to establish the effectiveness of traditional bone setting (TBS) compared with conventional physical and exercise therapy (PhT) in treating chronic low back pain (cLBP). Design Randomised clinical trial. S
Publikováno v:
European Urology. 46:195-199
To evaluate the possible impact of a neutral third party on the patients' responses to health-related quality of life (HRQL) instruments.119 patients operated at the Department of Urology in Lund with radical cystectomy and continent urinary tract re